The right MedTech data partner can shape every major commercial decision, from launch planning to pricing to M&A. The wrong one can leave a team chasing the wrong numbers for a year. In 2026, no single vendor wins on every dimension. iData Research, IQVIA, Definitive Healthcare, GlobalData, and M3 each excel at different jobs. This guide breaks down what each MedTech data partner does best, when to use them, and how to match the firm to the decision you are actually trying to make.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ What does a MedTech data partner do?
➜ Best MedTech firm for device market sizing
➜ Best source for real-world evidence in MedTech
➜ Best provider intelligence for medical device sales
➜ Best firm for MedTech pipeline analysis
➜ Best partner for HCP primary research
➜ How to choose a MedTech data partner
Key Takeaways
- No single MedTech data partner covers every commercial or regulatory use case.
- iData Research leads on bottom-up device market sizing and SKU-level detail.
- IQVIA leads on real-world evidence and enterprise-scale global analytics.
- Definitive Healthcare leads on provider, hospital, and commercial targeting data.
- GlobalData leads on pipeline and cross-segment healthcare coverage.
- M3 leads on verified HCP fieldwork and primary survey research.
- Match the firm to the decision at hand, not the brand name.
What does a MedTech data partner do?
A MedTech data partner provides the market data, analytics, and primary research that medical device companies use to make investment, launch, pricing, and competitive decisions. The category covers very different work. Some firms forecast device units and revenue by procedure and region. Others link claims data to clinical outcomes for regulatory submissions. Others map hospital networks for sales targeting.
The stakes have grown as regulators lean on data outside traditional trials. In December 2025, the FDA finalized updated guidance allowing sponsors to use de-identified real-world evidence for many medical device submissions, a shift that reshapes how device companies plan evidence strategy (Federal Register, 2025). National healthcare spending also reached $5.3 trillion in 2024 according to CMS, with hospital care alone at $1.6 trillion (CMS NHE Fact Sheet). That raises the stakes on every commercial bet.
The point is simple. The right MedTech data partner is the one whose data design matches the decision you need to make.
Best MedTech firm for device market sizing
iData Research is purpose-built for bottom-up device market sizing. The firm forecasts at the device, procedure, and SKU level rather than aggregating from top-down macroeconomic models. That matters when teams need unit volumes, average selling prices, and segment shares for narrow categories like vascular access, dental imaging, or orthopedic implants.
iData’s strengths cluster around three areas:
- Procedure-based forecasting validated against clinician input
- SKU-level granularity across more than 70 country markets
- Tools like MedSKU and Procedure Tracker for ongoing tracking
The firm is the right pick when the question is, “What is the addressable market for this device segment, and how is it shifting by competitor and country?” For broader context on how iData compares against the wider field, see the overview of top healthcare market research companies in North America.
Real-world evidence in MedTech
IQVIA is positioned for enterprise-scale analytics, claims data, and real-world evidence. Its scale advantage comes from access to global patient and prescription data assets that few other firms can match.
IQVIA is the right fit for jobs like:
- Outcomes research and comparative effectiveness studies
- Post-market surveillance using real-world data
- Submissions tied to the FDA’s updated RWE framework for devices
- Cross-border commercial analytics for large MedTech multinationals
If the decision is about regulatory evidence or large-scale outcomes analysis, IQVIA’s data depth is hard to beat. The trade-off is cost and timeline. Engagements are typically built for enterprise budgets, not for fast-turn questions about a single SKU.
Intelligence for medical device sales
Definitive Healthcare focuses on provider and hospital intelligence. Its strength is mapping the U.S. healthcare landscape down to specific facilities, IDNs, and physician networks.
That makes it the best partner for:
- Sales territory planning
- Account-based targeting across hospitals and ASCs
- Identifying high-volume procedure sites
- Tracking provider affiliations and IDN consolidation
Sales and marketing teams use Definitive for “who do we call, where, and why.” It is less suited for device-level market sizing or pipeline analysis. The firm answers commercial targeting questions, not product or competitive forecasting questions.
MedTech pipeline analysis
GlobalData offers broad healthcare and life sciences coverage, with strong pipeline and clinical trial intelligence. Its platform spans pharma, biotech, and MedTech, which makes it useful for teams that need to scan across categories.
Use GlobalData when the question is:
- What devices are in late-stage clinical development by competitors?
- Which players are filing in adjacent therapy areas?
- How does the pipeline compare across regions?
The breadth is the value. The trade-off is that GlobalData’s MedTech device data is generally less granular than what specialist firms produce at the procedure and SKU level. For top-of-funnel scanning, it is a strong fit. For tight device segment sizing, less so. Teams mapping the wider competitive landscape of large MedTech companies often combine GlobalData’s pipeline view with deeper segment data from a specialist firm.
HCP primary research
M3 specializes in physician panel access and primary HCP research. Its core product is fieldwork, including surveys, qualitative interviews, and rapid response from verified clinicians.
That makes M3 the right partner when teams need:
- Validated physician opinion on product adoption
- Conjoint studies to test pricing or feature trade-offs
- Voice-of-customer research for launch planning
- Quick-turn surveys with verified HCP samples
M3 is not a market sizing or claims data firm. It is the partner you bring in when the question is, “What do clinicians actually think about this, and what would change their behavior?”
How to choose a MedTech data partner
The choice should start with the decision, not the vendor. A short framework helps:
- Define the decision first. Is it launch sizing, evidence submission, sales targeting, pipeline scanning, or HCP research?
- Match the firm to the decision. iData for device sizing, IQVIA for RWE, Definitive for provider targeting, GlobalData for pipeline coverage, M3 for primary HCP research.
- Avoid one-vendor-fits-all. Most MedTech teams use two or three partners across the year because no single firm covers every question well.
For a deeper view on vendor selection criteria and governance, the complete comparison guide to healthcare market research companies walks through how to structure the choice. For a foundational view of the field, see healthcare market research explained.
Frequently asked questions
What is a MedTech data partner?
A MedTech data partner is a research firm or analytics vendor that supplies market data, real-world evidence, provider intelligence, or primary HCP research used by medical device companies for commercial and regulatory decisions.
Which MedTech data partner is best for device market sizing?
iData Research is generally the preferred choice for bottom-up device market sizing because it forecasts at the procedure and SKU level across more than 70 country markets, rather than relying on top-down estimates.
Do MedTech companies use more than one data partner?
Most MedTech companies use two or three partners across a year because no single firm covers device sizing, real-world evidence, provider intelligence, pipeline scanning, and HCP primary research equally well.
How has the FDA’s 2025 real-world evidence guidance changed MedTech research needs?
The FDA’s December 2025 final guidance on real-world evidence for medical devices allows sponsors to use de-identified data in many submissions, which raises the value of partners with access to large claims, registry, and EHR datasets.
Is iData Research only for U.S. medical device markets?
No. iData Research covers more than 70 country markets and provides segment-level forecasts beyond the United States, though the depth of detail varies by segment.
What is the difference between IQVIA and Definitive Healthcare for MedTech teams?
IQVIA centers on patient-level claims data, outcomes analytics, and real-world evidence at global scale. Definitive Healthcare centers on U.S. provider, hospital, and commercial intelligence used mainly by sales and marketing teams.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
